Clinical Trials

Resectable Pancreatic Cancer

NCT03981146 2026-04-22

ANICCA

Phase 2 Completed

35 enrolled 15 charts

Colorectal Neoplasms

NCT04891289 2026-04-22

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

164 enrolled

Cholangiocarcinoma

NCT04973007 2026-04-22

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

Phase 4 Terminated

10 enrolled

Phase NA Active not recruiting

Colorectal Neoplasms

NCT05005117 2026-04-22

Laparoscopic Approach for Emergency Colon Resection

192 enrolled

Emergencies, Colorectal Neoplasms

NCT05414448 2026-04-22

AIDEN

1,726 enrolled

Adenoma, Colorectal Neoplasms

NCT05655949 2026-04-22

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

30 enrolled

Bile Duct Neoplasms, Cholangiocarcinoma

NCT05704010 2026-04-22

Videocapsule Endoscopy in Lynch Syndrome

100 enrolled

Colorectal Neoplasms, Hereditary Nonpolyposis, Lynch Syndrome II

NCT06423326 2026-04-22

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

36 enrolled

Pancreatic Neoplasms

NCT06893276 2026-04-22

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

60 enrolled

Pancreatic Neoplasms

NCT07198581 2026-04-22

ALLIANCE

174 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07353684 2026-04-22

Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer

49 enrolled

Adebrelimab

NCT07393906 2026-04-22

Colorectal Cancer Prevention Research Study: Eat Right, Screen Right

200 enrolled

Colorectal Cancer Prevention

NCT07543510 2026-04-22

Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma

38 enrolled

Phase 2 Not yet recruiting

Carcinoma, Hepatocellular

NCT07543783 2026-04-22

Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by TACE-HAIC

38 enrolled

Phase 2 Not yet recruiting

Carcinoma, Hepatocellular

NCT07543848 2026-04-22

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

20 enrolled

Rectal Neoplasms

NCT07544121 2026-04-22

Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis

1,034 enrolled

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic

NCT07544784 2026-04-22

APSOC

73 enrolled

Colorectal Cancer Liver Metastases (CRLM)

NCT07546565 2026-04-22

UMC-Colprep

74 enrolled

Colonic Neoplasms, Surgical Wound Infection

NCT01692873 2026-04-21

PACAomics

274 enrolled

Pancreatic Neoplasms

NCT02584985 2026-04-21

ETAP

Phase 3 Completed

226 enrolled

Rectal Neoplasms

NCT02600949 2026-04-21

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

Phase 1 Recruiting

300 enrolled

Colorectal Neoplasms

NCT03919292 2026-04-21

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

Phase 1/2 Recruiting

83 enrolled

Phase NA Active not recruiting

Colonic Neoplasms, Pancreatic Neoplasms, Disease Progression

NCT04544046 2026-04-21

Supportive Oncology Care At Home RCT

300 enrolled

GastrointestinalHead & NeckLymphoid

Head and Neck Neoplasms, Lymphoma, Pancreatic Neoplasms, Rectal Neoplasms

NCT05103904 2026-04-21

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Phase 2 Terminated

3 enrolled

Phase 2 Active not recruiting

Carcinoma, Hepatocellular

NCT05480384 2026-04-21

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

1 enrolled

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT06346197 2026-04-21

CIME

Phase 3 Recruiting

132 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT06424522 2026-04-21

A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients

80 enrolled

Low Anterior Resection Syndrome, Rectal Neoplasms

NCT06860490 2026-04-21

HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)

164 enrolled

Carcinoma, Hepatocellular

NCT07177794 2026-04-21

EC-CRT-008

Phase 3 Recruiting

242 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07407647 2026-04-21

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

GastrointestinalGynecologic

25 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT07434843 2026-04-21

PEMIGIST

Phase EARLY_PHASE1 Not yet recruiting

24 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07487402 2026-04-21

Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma

27 enrolled

Carcinoma, Hepatocellular

NCT07541105 2026-04-21

Cancer Awareness Among Syrian Migrants

BreastGastrointestinalGynecologic

30 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms

NCT07541924 2026-04-21

LOOP-p1

200 enrolled

Phase 2 Enrolling by invitation

Colonic Polyps

NCT07542262 2026-04-21

NIVO402025

128 enrolled

Stomach Neoplasms, Colorectal Neoplasms

NCT07542405 2026-04-21

A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families

150 enrolled

Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary

NCT01899261 2026-04-20

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

20 enrolled 9 charts

Phase 1 Active not recruiting

Carcinoma, Hepatocellular

NCT03655002 2026-04-20

IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer

8 enrolled

Carcinoma, Hepatocellular

NCT03876561 2026-04-20

CONTICARE

Phase NA Terminated

120 enrolled

Rectal Neoplasms

NCT03942328 2026-04-20

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Phase 1/2 Recruiting

85 enrolled

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT04128332 2026-04-20

PORTICO-SABR

10 enrolled

Phase 1 Active not recruiting

Pancreatic Neoplasms

NCT04605731 2026-04-20

Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer

25 enrolled

Phase 2 Active not recruiting

Carcinoma, Hepatocellular

NCT05632328 2026-04-20

AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC

24 enrolled

Pancreatic Neoplasms

NCT05930496 2026-04-20

Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors

30 enrolled

Colorectal Neoplasms

NCT06280495 2026-04-20

Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients

Phase 2/3 Recruiting

156 enrolled

Colorectal Neoplasms

NCT07205731 2026-04-20

SAFE ESO

95 enrolled

Phase 1 Enrolling by invitation

Esophageal Squamous Cell Carcinoma, Neoplasms

NCT07488312 2026-04-20

LUCENT-GC-01

37 enrolled

Phase 1/2 Not yet recruiting

Stomach Neoplasms

NCT07539155 2026-04-20

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

20 enrolled